MUCINEX Drug Patent Profile

✉ Email this page to a colleague

When do Mucinex patents expire, and when can generic versions of Mucinex launch?

Mucinex is a drug marketed by Rb Hlth and is included in three NDAs.

The generic ingredient in MUCINEX is dextromethorphan hydrobromide; guaifenesin. There are twenty-three drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; guaifenesin profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for MUCINEX?
What are the global sales for MUCINEX?
What is Average Wholesale Price for MUCINEX?

Summary for MUCINEX

US Patents:	0
Applicants:	1
NDAs:	3
Finished Product Suppliers / Packagers:	9
Raw Ingredient (Bulk) Api Vendors:	122
Clinical Trials:	16
Patent Applications:	3,054
Drug Prices:	Drug price information for MUCINEX
Drug Sales Revenues:	Drug sales revenues for MUCINEX
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for MUCINEX
What excipients (inactive ingredients) are in MUCINEX?	MUCINEX excipients list
DailyMed Link:	MUCINEX at DailyMed

Drug patent expirations by year for MUCINEX

Recent Clinical Trials for MUCINEX

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
American Health Research	Phase 4
Vitaccess Ltd	Phase 4
Massachusetts Eye and Ear Infirmary	N/A

See all MUCINEX clinical trials

Pharmacology for MUCINEX

Drug Class	Expectorant
Physiological Effect	Decreased Respiratory Secretion Viscosity Increased Respiratory Secretions

Paragraph IV (Patent) Challenges for MUCINEX

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
MUCINEX	Extended-release Tablets	guaifenesin	600 mg and 1.2 gm	021282	1	2006-06-09

US Patents and Regulatory Information for MUCINEX

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Rb Hlth	MUCINEX	guaifenesin	TABLET, EXTENDED RELEASE;ORAL	021282-002	Dec 18, 2002		OTC	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Rb Hlth	MUCINEX D	guaifenesin; pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021585-001	Jun 22, 2004		OTC	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Rb Hlth	MUCINEX	guaifenesin	TABLET, EXTENDED RELEASE;ORAL	021282-001	Jul 12, 2002		OTC	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Rb Hlth	MUCINEX D	guaifenesin; pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021585-002	Jun 22, 2004		OTC	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Rb Hlth	MUCINEX DM	dextromethorphan hydrobromide; guaifenesin	TABLET, EXTENDED RELEASE;ORAL	021620-001	Apr 29, 2004		OTC	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Rb Hlth	MUCINEX DM	dextromethorphan hydrobromide; guaifenesin	TABLET, EXTENDED RELEASE;ORAL	021620-002	Apr 29, 2004		OTC	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for MUCINEX

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Rb Hlth	MUCINEX	guaifenesin	TABLET, EXTENDED RELEASE;ORAL	021282-002	Dec 18, 2002	⤷ Sign Up	⤷ Sign Up
Rb Hlth	MUCINEX	guaifenesin	TABLET, EXTENDED RELEASE;ORAL	021282-001	Jul 12, 2002	⤷ Sign Up	⤷ Sign Up
Rb Hlth	MUCINEX	guaifenesin	TABLET, EXTENDED RELEASE;ORAL	021282-001	Jul 12, 2002	⤷ Sign Up	⤷ Sign Up
Rb Hlth	MUCINEX	guaifenesin	TABLET, EXTENDED RELEASE;ORAL	021282-001	Jul 12, 2002	⤷ Sign Up	⤷ Sign Up
Rb Hlth	MUCINEX	guaifenesin	TABLET, EXTENDED RELEASE;ORAL	021282-002	Dec 18, 2002	⤷ Sign Up	⤷ Sign Up
Rb Hlth	MUCINEX	guaifenesin	TABLET, EXTENDED RELEASE;ORAL	021282-002	Dec 18, 2002	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for MUCINEX

See the table below for patents covering MUCINEX around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Taiwan	200400836		⤷ Sign Up
World Intellectual Property Organization (WIPO)	03088952		⤷ Sign Up
Japan	2003531849		⤷ Sign Up
Israel	190742		⤷ Sign Up
Israel	164438		⤷ Sign Up
Eurasian Patent Organization	200401369		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration